Bonus BioGroup (TASE: BONS) is a clinical-stage Israeli biotechnology company engaged in the R&D of tissue-engineered and cell therapy products. Bonus CEO Dr. Shai Meretzki, one of Israel's most prominent biotech entrepreneurs, founded Bonus to build live tissues outside the body. He started with bones, developing BonoFill, the world's first tissue-engineered viable bone graft for treating severe bone defects currently under-treated by transplanting bone from another part of the body with considerable limitations. The active ingredients in BonoFill are mesenchymal cells isolated from the patient's adipose tissue. Using BonoFill, bones were successfully regenerated in already dozens of patients that recovered from years of disabilities. During the coronavirus outbreak, Bonus started developing MesenCure based on mesenchymal cells to treat life-threatening pneumonia and cytokine storm in severe Covid-19 patients. With excellent clinical results and established manufacturing capacity, Bonus strives to continue saving and improving patients' lives and becoming a world leader in regenerative medicine.
Company Details
- Employees
- 42
- Address
- 8 Nahum Hat (נחום חת), P.o.b 15143,israel
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- bonusbiogroup.com
- Keywords
- Bone tissue engineering, Biotechnology, Adipose-derived stem cells, Mesenchymal stem cells, Critical gap bone fractures, Maxillofacial tissue engineering, Biomedical Engineering, Orthopedics, Innovation.
- HQ
- Haifa, Matam Advanced Technology Park
Bonus Biogroup Questions
Bonus Biogroup's website is bonusbiogroup.com
Bonus Biogroup's LinkedIn profile is https://il.linkedin.com/company/bonus-biogroup
Bonus Biogroup has
42 employees.
View email and phone details for 42
employees at Bonus Biogroup.
Bonus Biogroup's industry is
Biotechnology Research
Bonus Biogroup's top competitors are
Protalix Biotherapeutics,
Evogene,
Novocure,
Nurexone Biologic (Otcqb:nrxbf) (Tsxv: Nrx) (Fse: J90),
Minovia Therapeutics,
Gsap,
Pluri,
Imagindairy,
Ever After Foods,
Memed.
Bonus Biogroup's support email address is info@bonus-bio.com
Bonus Biogroup's categories are Biotechnology Research
